IL6 and metabolic syndrome: The figure shows how the inflammatory markers of RA (IL‐6, TNF‐alpha, rheumatoid factor, etc,) can favor a response in different organs and tissues associated with the pathogenesis of MetS, such as the liver, pancreas, and the cardiovascular system, thus favoring the development of insulin resistance, atherosclerosis, and chronic inflammation.